BamSEC and AlphaSense Join Forces
Learn More

Rhythm Pharmaceuticals Inc. – Material Contracts

NASDAQ: RYTM    
Share price (3/24/26): $82.59    
Market cap (3/24/26): $5.640 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.17
from 10-K 8 pages May 20, 2024 Alastair Garfield via Email [Redacted] Dear Alastair,
12/34/56
EX-10.1
from 10-Q 4 pages Rhythm Pharmaceuticals, Inc. ​ Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 10-Q 3 pages Rhythm Pharmaceuticals, Inc. ​ Non-Employee Director Compensation Program
12/34/56
EX-10.5
from 10-Q 6 pages Two Twenty-Two Berkeley Street Boston, Ma Third Amendment to Lease Rhythm Pharmaceuticals, Inc
12/34/56
EX-10.4
from 10-Q 7 pages ​ Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan Performance Unit Agreement
12/34/56
EX-10.1
from 10-Q 1 page Summary of Non-Employee Director Compensation Policy Under the Company’s Non-Employee Director Compensation Policy, All Non-Employee Directors Will Be Paid an Annual Retainer Fee of $50,000 and Such Additional Fees as Are Set Forth in the Following Table. All Payments Will Be Made Quarterly in Arrears
12/34/56
EX-10.1
from 8-K 126 pages List of Exhibits
12/34/56
EX-10.25
from 10-K 62 pages Exclusive License Agreement
12/34/56
EX-10.6
from 10-K ~1 page ​ Summary of Non-Employee Director Compensation Policy Under the Company’s Non-Employee Director Compensation Policy, All Non-Employee Directors Will Be Paid an Annual Retainer Fee of $50,000 and Such Additional Fees as Are Set Forth in the Following Table. All Payments Will Be Made Quarterly in Arrears
12/34/56
EX-10.4
from 8-K 8 pages Material contract
12/34/56
EX-10.3
from 8-K 7 pages Material contract
12/34/56
EX-10.2
from 8-K 8 pages Material contract
12/34/56
EX-10.1
from 8-K 8 pages Material contract
12/34/56
EX-10.20
from 10-K 7 pages ​ June 23, 2020 ​ Joe Shulman 116 Auburn Street Newton, Ma 02466 ​ Dear Joe ​
12/34/56
EX-10.6
from 10-K ~1 page ​ Summary of Non-Employee Director Compensation Policy Under the Company’s Non-Employee Director Compensation Policy, All Non-Employee Directors Will Be Paid an Annual Retainer Fee of $50,000 and Such Additional Fees as Are Set Forth in the Following Table. All Payments Will Be Made Quarterly in Arrears
12/34/56
EX-10.1
from 10-Q 120 pages Revenue Interest Financing Agreement by and Among Rhythm Pharmaceuticals, Inc., as the Company, Entities Managed by Healthcare Royalty Management, LLC, as the Investors, and Hcr Collateral Management, LLC, as the Investor Representative Dated June 16, 2022
12/34/56
EX-10.21.2
from 10-K 17 pages Consulting Agreement
12/34/56
EX-10.10
from 10-K 62 pages Exclusive License Agreement
12/34/56
EX-10.6
from 10-K 1 page ​ Summary of Non-Employee Director Compensation Policy Under the Company’s Non-Employee Director Compensation Policy, All Non-Employee Directors Will Be Paid an Annual Retainer Fee of $47,500 and Such Additional Fees as Are Set Forth in the Following Table. All Payments Will Be Made Quarterly in Arrears
12/34/56
EX-10.5.2
from 10-K 5 pages Rhythm Pharmaceuticals, Inc. 2022 Employment Inducement Plan Restricted Stock Unit Agreement
12/34/56